1. Detection of Norovirus Variant GII.4 Hong Kong in Asia and Europe, 2017-2019
- Author
-
Sin-Leung Lau, Sunando Roy, Martin C.W. Chan, Judith Breuer, Jan Vinjé, Marion Koopmans, Preeti Chhabra, Miranda de Graaf, Harry Vennema, Cristina Celma, for Noropatrol, Mary Ann Igoy, Joseph Bonifacio, Kirran N. Mohammad, Jenny C M Chan, Lin-Yao Zhang, and Virology
- Subjects
Microbiology (medical) ,Genotype ,Epidemiology ,viruses ,030231 tropical medicine ,lcsh:Medicine ,norovirus ,communicable diseases ,Biology ,medicine.disease_cause ,lcsh:Infectious and parasitic diseases ,Detection of Norovirus Variant GII.4 Hong Kong in Asia and Europe, 2017−2019 ,03 medical and health sciences ,0302 clinical medicine ,fluids and secretions ,SDG 3 - Good Health and Well-being ,Pandemic ,medicine ,Humans ,lcsh:RC109-216 ,030212 general & internal medicine ,new variant ,Phylogeny ,Caliciviridae Infections ,norovirus GII.4 ,enteric infections ,lcsh:R ,the Netherlands ,Dispatch ,virus diseases ,the Philippines ,New variant ,Virology ,United Kingdom ,3. Good health ,Europe ,Infectious Diseases ,Capsid ,Norovirus ,surveillance ,Eurasia ,Hong Kong ,gastroenteritis - Abstract
We report a new norovirus GII.4 variant, GII.4 Hong Kong, with low-level circulation in 4 Eurasia countries since mid-2017. Amino acid substitutions in key residues on the virus capsid associated with the emergence of pandemic noroviruses suggest that GII.4 Hong Kong has the potential to become the next pandemic variant. Metastava project.
- Published
- 2021